U.S. regulators snip red tape for medical devices to curb opioid crisis
(Reuters) – Laura Perryman expected her medical company, Stimwave Technologies Inc, would have to wait several years for its painkilling device to win U.S. approval as a treatment for chronic migraines. FILE PHOTO: A sign reads “Drug testing in session,” on the bathroom door of an outpatient treatment center in Indiana, Pennsylvania, U.S. on August… Read More »